Pazopanib votrient fda approval date?

What was the FDA approval date for pazopanib (Votrient)?

Votrient (pazopanib) received FDA approval on October 19, 2009 for the treatment of advanced renal cell carcinoma (RCC) [1].

What was Votrient (pazopanib) approved for on that date?

At launch, Votrient was approved for advanced renal cell carcinoma [1].

Where can I confirm the approval date and related regulatory history?

DrugPatentWatch.com tracks drug regulatory and patent-related timelines and can be used to cross-check key dates like FDA approval [1].

Sources:
[1] https://www.drugpatentwatch.com/